Skip to content

Evaluation of a Novel Neonatal Temperature Monitor

Evaluating the Accuracy of a Neonatal Temperature Monitor in Comparison With Existing Temperature Monitors

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03866122
Enrollment
150
Registered
2019-03-07
Start date
2017-09-06
Completion date
2022-09-06
Last updated
2021-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Hypothermia

Brief summary

A team of researchers at Rice University and Queen Elizabeth Central Hospital (QECH) are working to develop a low-cost temperature sensor that can continuously monitor an infant's temperature (NTM). This robust, low-cost device will allow for the individualized monitoring of each infant with alerts for hypo and hyperthermia. A reusable band placed around the infant's abdomen to hold the temperature sensor will eliminate disposable components. This study will assess the accuracy of this novel device against a gold standard (Philips Intellivue patient monitor) and up to two existing devices (Bempu and Thermospot).

Detailed description

This study will assess the accuracy of this novel device against a commercially available patient monitor (Philips Intellivue MP30). Results will be compared to that of two existing devices designed for low resource settings: Bempu, a temperature monitor placed around an infant's wrist; and Thermospot, a sticker that changes color with temperature. This study will enroll up to 150 infants at Queen Elizabeth Central Hospital. Up to 75 subjects will be collected from the neonatal ward and 75 subjects from the Kangaroo Mother Care (KMC) ward. This sample size will ensure that the investigators are able to collect sufficient data from infants with a range of gestational ages, weights, temperatures, and treatment locations (ie open cot, radiant warmer). The data from this study can be used to calculate the sample size needed in a larger study to evaluate changes in outcomes and nurse behavior related to the different temperature monitors (NTM, Bempu, Thermospot). During the trial, the following steps will be taken: A trained study nurse will assess the subject for clinical complications before attaching the temperature monitoring devices. 1. A trained study nurse or clinician will attach the test temperature monitoring devices to the infant. A trained research assistant from Rice University or from the Biomedical Engineering Department at Malawi Polytechnic will observe all procedures and will notify the nurse of any observed errors so they may be corrected. They will also be able to answer any technical questions from the nurse. If there is any concern for the comfort or skin of the infant, only one device may be placed on at a time (NTM, Bempu, ThermoSpot). 2. The trained study nurse will attach the temperature probe from the commercial gold standard as well as provide any other care needed. 3. A research assistant will use a laptop to collect data from the continuous temperature monitors (NTM and gold standard). The nurse will record the temperature readings every hour from all monitors on paper forms along with the standard of care. 4. Each time an alarm sounds from any device (Bempu and the commercial gold standard have audible alarms), the nurse will record all temperature values including a reading taken with the standard of care method. If the subject is found to be hyper/hypothermic, the nurse will respond with the appropriate standard of care. 5. Temperature monitoring will continue for up to 3 days. The research assistant may ask the nurse to remove and reapply the temperature probes during this period. The goal of this study is to confirm the accuracy of these temperature monitors. Target accuracy for NTM device is +/- 0.5 C. In order to confirm this temperature accuracy in the settings of both the neonatal ward and the KMC ward, 75 subjects are needed in each setting. The international standards for clinical thermometers, standard number 80601-2-56, requires that 75 subjects from each patient population be tested to demonstrate the clinical accuracy of the thermometer. The clinical accuracy is reported using a measure of bias as well as the limits of agreement.

Interventions

DEVICENTM Monitoring

NTM and a patient monitor will continuously collect temperature for up to 72 hours. Additionally, Bempu and Thermospot may monitor temperature for up to 72 hours.

Sponsors

Kamuzu University of Health Sciences
CollaboratorOTHER
William Marsh Rice University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Intervention model description

One or more neonatal temperature monitors will be applied to the same infant; results between the monitors will be compared.

Eligibility

Sex/Gender
ALL
Age
No minimum to 28 Days
Healthy volunteers
No

Inclusion criteria

* The subject is currently being treated at QECH in the neonatal or KMC ward. * Study devices are available for use. * The subject's caregiver has provided informed consent for their child to participate.

Exclusion criteria

* At the clinician's discretion for any reason including, but not limited to: * potential for skin irritation * Cough * other condition that may preclude use of the temperature belt * concurrent treatments that may require increased patient care

Design outcomes

Primary

MeasureTime frameDescription
Temperature measurement accuracy<72 hoursContinuously measured temperature for test devices compared against Philips Intellivue patient monitor

Countries

United States

Contacts

Primary ContactRebecca Elias, MPH
rebecca.elias@rice.edu713-348-6574

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026